Target intelligence / Profile preview

Microcephalin 1 (MCPH1)

Target
MCPH1
Molecular classification
Other (BRCT domain-containing signaling protein; not a receptor, enzyme, ion channel, transporter, or transcription factor)
01

Overview

Microcephalin 1 (MCPH1) is a multifunctional, evolutionarily conserved protein encoded by the MCPH1 gene on chromosome 8p23.1. The canonical full-length protein contains 835 amino acids and includes three BRCT (BRCA1 C-Terminal) domains, key for protein-protein interactions in DNA repair, cell cycle checkpoints, and chromatin remodeling. MCPH1 plays a central role in regulating chromosome condensation during the G2/M phase transition, facilitating DNA repair via interaction with multiple DNA repair proteins, and is involved in the control of centrosome and spindle function during mitosis. Loss-of-function mutations in MCPH1 cause autosomal recessive primary microcephaly, characterized by severely reduced brain size and intellectual disability. Additionally, MCPH1 acts as a tumor suppressor and is implicated in the maintenance of genome integrity. No drugs are known to directly interact with MCPH1, and it is not currently considered a therapeutic target.

Other names
MicrocephalinBRIT1BRCT-repeat inhibitor of TERT expression 1MCTFLJ12847
02

Mechanism of action

Not applicable; no direct drug mechanisms established for this protein

03

Biological functions

DNA damage response and DNA repairCell cycle regulation (especially chromosome condensation, transition through G2/M phases, mitosis)Regulation of chromatin structure and remodelingBrain development and neuronal proliferationTumor suppressionCentrosome and spindle pole organization during mitosis
04

Disease associations

Primary autosomal recessive microcephaly (congenital neurodevelopmental disorder)Cancer (tumor suppression)Infertility (primarily in mouse models—smaller testis/ovary, spermatogenesis/follicle defects)
05

Safety considerations

None directly related to drug targeting, but loss-of-function mutations cause neurodevelopmental disorders including primary microcephaly, and contribute to genomic instability and tumorigenesis
06

Biomarkers

Mutations in MCPH1 can serve as diagnostic biomarkers for primary microcephaly and (potentially) genetic cancer predisposition

Beyond the preview

Go deeper on Microcephalin 1 (MCPH1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microcephalin 1 (MCPH1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call